Fortfahren mit
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 10 μg | Warenkorb auf Verfügbarkeit prüfen | CHF 612.00 |
Über diesen Artikel
UNSPSC Code:
12352204
NACRES:
NA.54
EG-Nummer:
3.4.14.-
Specific activity:
≥1,500 units/μg protein, ≥1500 units/μg protein
Recombinant:
expressed in Sf9 cells
CHF 612.00
Warenkorb auf Verfügbarkeit prüfen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenrecombinant
expressed in Sf9 cells
Quality Level
form
solution
specific activity
≥1,500 units/μg protein, ≥1500 units/μg protein
mol wt
89.1 kDa
relevant disease(s)
diabetes; cardiovascular diseases
shipped in
dry ice
storage temp.
−70°C
General description
Contains amino acids 29 to end with a C-terminal His tag, MW=89.1 kDa
Application
Dipeptidyl Peptidase VII (DPP7), also known as DPP2 or quiescent cell proline dipeptidase, is a post-proline cleaving aminopeptidase that is expressed in quiescent lymphocytes [1]. DPP7 is used to study the regulation of cell quiescence . Like DPP4, DPP7 may be useful in diabetes and vascular disease research [2].
Biochem/physiol Actions
DPP7 is essential for maintaining lymphocytes and fibroblasts in G(0). The inhibition of DPP7 results in apoptosis, which is mediated by the induction of c-Myc and p53 . DPP7 has strong sequence homology with prolylcarboxypeptidase and is active at both acidic and neutral pH.
Physical form
Supplied as a solution in 40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 220 mM imidazole, and 20% glycerol.
Other Notes
One unit will hydrolyze 1.0 picomole of Ala-Pro-AMC per minute at pH 7.4 at 25 deg °C
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| specific activity ≥1,500 units/μg protein, ≥1500 units/μg protein | specific activity ≥250 units/μg protein | specific activity ≥20 units/μg protein | specific activity ≥400 units/μg protein |
| recombinant expressed in Sf9 cells | recombinant expressed in Sf9 cells | recombinant expressed in Sf9 cells | recombinant expressed in Sf9 cells |
| form solution | form solution | form solution | form solution |
| storage temp. −70°C | storage temp. −70°C | storage temp. −70°C | storage temp. −70°C |
| shipped in dry ice | shipped in dry ice | shipped in dry ice | shipped in dry ice |
| mol wt 89.1 kDa | mol wt - | mol wt 100 kDa | mol wt 82 kDa |
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Repr. 1B - Skin Corr. 1C
Lagerklasse
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 2
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Dolan Sondhi et al.
Human gene therapy methods, 23(5), 324-335 (2012-11-08)
Late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal, lysosomal storage disorder caused by mutations in the CLN2 gene, results in a deficiency of tripeptidyl-peptidase I (TPP-I) activity in neurons. Our prior studies showed that delivery of the human CLN2 cDNA
Wengen Wu et al.
Bioorganic & medicinal chemistry letters, 22(17), 5536-5540 (2012-08-03)
The boroProline-based dipeptidyl boronic acids were among the first DPP-IV inhibitors identified, and remain the most potent known. We introduced various substitutions at the 4-position of the boroProline ring regioselectively and stereoselectively, and incorporated these aminoboronic acids into a series
Katrin Witzel et al.
Neuropharmacology, 63(8), 1389-1403 (2012-09-12)
We examined the effects of the sulfonylurea compound NS5806 on neuronal A-type channel function. Using whole-cell patch-clamp we studied the effects of NS5806 on the somatodendritic A-type current (I(SA)) in cultured hippocampal neurons and the currents mediated by Kv4.2 channels
Global Trade Item Number
| SKU | GTIN |
|---|---|
| D3321-10UG | 04061832700496 |





